Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide. (2012)
Attributed to:
Expansion of the GMP facility for Stem Cell Therapy at Imperial College
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bbmt.2011.10.003
PubMed Identifier: 22001752
Publication URI: http://europepmc.org/abstract/MED/22001752
Type: Journal Article/Review
Volume: 18
Parent Publication: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Issue: 2
ISSN: 1083-8791